Owner Spectrum Pharmaceuticals, Inc.

Inventors Nawrocki, Steffan T.; Carew, Jennifer S.; Reddy, Guru

Agent Wrays

Pub. Number AU-A-2011224445

PCT Pub. Number WO2011/112623

Priority 61/311,736 08.03.10 US

Filing date 8 March 2011

Wipo publication date 15 September 2011

A61K 31/00

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/18 - Sulfonamides

A61K 31/19

A61K 31/222

A61K 31/337 - having four-membered rings, e.g. taxol

A61K 31/343 - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/382 - having six-membered rings, e.g. thioxanthenes

A61K 31/39 - having oxygen atoms in the same ring

A61K 31/404

A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61K 33/36 Medicinal preparations containing inorganic active ingredients - Arsenic